{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T04:10:17Z","timestamp":1787803817787,"version":"build-2784847793"},"reference-count":199,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,28]],"date-time":"2021-11-28T00:00:00Z","timestamp":1638057600000},"content-version":"am","delay-in-days":331,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Lipid Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.plipres.2020.101079","type":"journal-article","created":{"date-parts":[[2020,11,28]],"date-time":"2020-11-28T18:24:51Z","timestamp":1606587891000},"page":"101079","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"special_numbering":"C","title":["Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain"],"prefix":"10.1016","volume":"81","author":[{"given":"Hiroshi","family":"Ueda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.plipres.2020.101079_bb0005","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S0301-0082(00)00063-0","article-title":"Prostaglandins and cyclooxygenases [correction of cycloxygenases] in the spinal cord","volume":"64","author":"Vanegas","year":"2001","journal-title":"Prog Neurobiol"},{"issue":"11","key":"10.1016\/j.plipres.2020.101079_bb0010","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.tins.2011.08.005","article-title":"Emerging roles of resolvins in the resolution of inflammation and pain","volume":"34","author":"Ji","year":"2011","journal-title":"Trends Neurosci"},{"issue":"7503","key":"10.1016\/j.plipres.2020.101079_bb0015","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nature13479","article-title":"Pro-resolving lipid mediators are leads for resolution physiology","volume":"510","author":"Serhan","year":"2014","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0020","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/nm.2123","article-title":"Resolvins RvE1 and RvD1 attenuate inflammatory pain via central and peripheral actions","volume":"16","author":"Xu","year":"2010","journal-title":"Nat Med"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0025","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.plipres.2020.101079_bb0030","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2017.06.015","article-title":"The cannabinoid system and pain","volume":"124","author":"Woodhams","year":"2017","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0035","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1093\/ajhp\/61.2.160","article-title":"Diabetic neuropathy: An intensive review","volume":"61","author":"Duby","year":"2004","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.plipres.2020.101079_bb0040","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s11892-019-1212-8","article-title":"Epidemiology of peripheral neuropathy and lower extremity disease in diabetes","volume":"19","author":"Hicks","year":"2019","journal-title":"Curr Diab Rep"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0045","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/j.pain.0000000000000307","article-title":"A systematic review and meta-analysis of risk factors for postherpetic neuralgia","volume":"157","author":"Forbes","year":"2016","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/j.pain.0000000000000722","article-title":"Animal models for central poststroke pain: A critical comprehensive review","volume":"158","author":"De Vloo","year":"2017","journal-title":"Pain"},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2020.101079_bb0055","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/j.pain.0000000000001540","article-title":"Chemotherapy-induced peripheral neuropathy: Where are we now?","volume":"160","author":"Colvin","year":"2019","journal-title":"Pain"},{"issue":"15","key":"10.1016\/j.plipres.2020.101079_bb0060","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: A clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.plipres.2020.101079_bb0065","doi-asserted-by":"crossref","first-page":"15022","DOI":"10.1038\/nrdp.2015.22","article-title":"Fibromyalgia","volume":"1","author":"Hauser","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.plipres.2020.101079_bb0070","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","article-title":"Neurobiology of fibromyalgia and chronic widespread pain","volume":"338","author":"Sluka","year":"2016","journal-title":"Neuroscience"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0075","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pain.2009.10.004","article-title":"Randomized controlled trials of psychological therapies for management of chronic pain in children and adolescents: an updated meta-analytic review","volume":"148","author":"Palermo","year":"2010","journal-title":"Pain"},{"issue":"4","key":"10.1016\/j.plipres.2020.101079_bb0080","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.pain.2013.11.013","article-title":"Neuropathic pain in the general population: A systematic review of epidemiological studies","volume":"155","author":"van Hecke","year":"2014","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0090","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","article-title":"2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria","volume":"46","author":"Wolfe","year":"2016","journal-title":"Semin Arthritis Rheum"},{"issue":"1 Suppl 88","key":"10.1016\/j.plipres.2020.101079_bb0095","first-page":"S33","article-title":"The rs3771863 single nucleotide polymorphism of the TACR1 gene is associated to a lower risk of sicca syndrome in fibromyalgia patients","volume":"33","author":"Rodriguez-Rodriguez","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0100","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1038\/sj.bjp.0704092","article-title":"Characterization of EP receptor subtypes responsible for prostaglandin E2-induced pain responses by use of EP1 and EP3 receptor knockout mice","volume":"133","author":"Minami","year":"2001","journal-title":"Br J Pharmacol"},{"issue":"6643","key":"10.1016\/j.plipres.2020.101079_bb0105","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1038\/41780","article-title":"Altered pain perception and inflammatory response in mice lacking prostacyclin receptor","volume":"388","author":"Murata","year":"1997","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0110","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1172\/JCI23618","article-title":"Spinal inflammatory hyperalgesia is mediated by prostaglandin E receptors of the EP2 subtype","volume":"115","author":"Reinold","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.plipres.2020.101079_bb0115","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-8069-1-3","article-title":"Sensitization of TRPV1 by EP1 and IP reveals peripheral nociceptive mechanism of prostaglandins","volume":"1","author":"Moriyama","year":"2005","journal-title":"Mol Pain"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031111","article-title":"Discovery of prostamide F2alpha and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability","volume":"7","author":"Gatta","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.plipres.2020.101079_bb0125","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1038\/bjp.2008.33","article-title":"Prostaglandin E2 glycerol ester, an endogenous COX-2 metabolite of 2-arachidonoylglycerol, induces hyperalgesia and modulates NFkappaB activity","volume":"153","author":"Hu","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.plipres.2020.101079_bb0130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12990-015-0059-5","article-title":"Leukotriene enhances NMDA-induced inward currents in dorsal horn neurons of the rat spinal cord after peripheral nerve injury","volume":"11","author":"Kiyoyuki","year":"2015","journal-title":"Mol Pain"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0135","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1248\/bpb.34.1163","article-title":"Leukotrienes in nociceptive pathway and neuropathic\/inflammatory pain","volume":"34","author":"Noguchi","year":"2011","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.plipres.2020.101079_bb0140","doi-asserted-by":"crossref","first-page":"6721","DOI":"10.1073\/pnas.1110460109","article-title":"Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors","volume":"109","author":"Gregus","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.plipres.2020.101079_bb0145","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1111\/bph.12665","article-title":"Update on leukotriene, lipoxin and oxoeicosanoid receptors: IUPHAR Review 7","volume":"171","author":"Back","year":"2014","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0150","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/pr.116.013177","article-title":"International union of basic and clinical pharmacology CIII: Chemerin receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) nomenclature, pharmacology, and function","volume":"70","author":"Kennedy","year":"2018","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.plipres.2020.101079_bb0155","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fphar.2018.01273","article-title":"Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease","volume":"9","author":"Pirault","year":"2018","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0160","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12974-016-0540-8","article-title":"Lipoxin A4 inhibits microglial activation and reduces neuroinflammation and neuropathic pain after spinal cord hemisection","volume":"13","author":"Martini","year":"2016","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0165","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ejpain.2011.05.005","article-title":"LipoxinA(4) induced antinociception and decreased expression of NF-kappaB and pro-inflammatory cytokines after chronic dorsal root ganglia compression in rats","volume":"16","author":"Sun","year":"2012","journal-title":"Eur J Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0170","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.neuroscience.2014.04.052","article-title":"Aspirin-triggered Lipoxin A4 attenuates mechanical allodynia in association with inhibiting spinal JAK2\/STAT3 signaling in neuropathic pain in rats","volume":"273","author":"Wang","year":"2014","journal-title":"Neuroscience"},{"issue":"25","key":"10.1016\/j.plipres.2020.101079_bb0175","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1074\/jbc.274.25.17777","article-title":"Molecular cloning, enzymatic characterization, developmental expression, and cellular localization of a mouse cytochrome P450 highly expressed in kidney","volume":"274","author":"Ma","year":"1999","journal-title":"J Biol Chem"},{"issue":"Suppl","key":"10.1016\/j.plipres.2020.101079_bb0180","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.1194\/jlr.R800038-JLR200","article-title":"Arachidonic acid cytochrome P450 epoxygenase pathway","volume":"50","author":"Spector","year":"2009","journal-title":"J Lipid Res"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0185","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1124\/dmd.115.064139","article-title":"Quantitative polymerase chain reaction analysis of the mouse Cyp2j subfamily: Tissue distribution and regulation","volume":"43","author":"Graves","year":"2015","journal-title":"Drug Metab Dispos"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0190","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1074\/jbc.M608057200","article-title":"Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice","volume":"282","author":"Luria","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2020.101079_bb0195","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pharmthera.2017.06.006","article-title":"Soluble epoxide hydrolase as a therapeutic target for pain, inflammatory and neurodegenerative diseases","volume":"180","author":"Wagner","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.plipres.2020.101079_bb0200","doi-asserted-by":"crossref","first-page":"4606","DOI":"10.1523\/JNEUROSCI.3069-18.2019","article-title":"Astrocytic epoxyeicosatrienoic acid signaling in the medial prefrontal cortex modulates depressive-like behaviors","volume":"39","author":"Xiong","year":"2019","journal-title":"J Neurosci"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0205","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1084\/jem.20020760","article-title":"Resolvins: A family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals","volume":"196","author":"Serhan","year":"2002","journal-title":"J Exp Med"},{"key":"10.1016\/j.plipres.2020.101079_bb0210","doi-asserted-by":"crossref","first-page":"745","DOI":"10.3389\/fphar.2019.00745","article-title":"Resolvin D5 inhibits neuropathic and inflammatory pain in male but not female mice: Distinct actions of D-series resolvins in chemotherapy-induced peripheral neuropathy","volume":"10","author":"Luo","year":"2019","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0215","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nn.4053","article-title":"Different immune cells mediate mechanical pain hypersensitivity in male and female mice","volume":"18","author":"Sorge","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.plipres.2020.101079_bb0220","doi-asserted-by":"crossref","first-page":"7906","DOI":"10.1074\/jbc.273.14.7906","article-title":"Characterization of a novel subtype of human G protein-coupled receptor for lysophosphatidic acid","volume":"273","author":"An","year":"1998","journal-title":"J Biol Chem"},{"issue":"39","key":"10.1016\/j.plipres.2020.101079_bb0225","doi-asserted-by":"crossref","first-page":"27776","DOI":"10.1074\/jbc.274.39.27776","article-title":"Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid","volume":"274","author":"Bandoh","year":"1999","journal-title":"J Biol Chem"},{"issue":"4","key":"10.1016\/j.plipres.2020.101079_bb0230","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1083\/jcb.135.4.1071","article-title":"Ventricular zone gene-1 (vzg-1) encodes a lysophosphatidic acid receptor expressed in neurogenic regions of the developing cerebral cortex","volume":"135","author":"Hecht","year":"1996","journal-title":"J Cell Biol"},{"key":"10.1016\/j.plipres.2020.101079_bb0235","doi-asserted-by":"crossref","first-page":"23589","DOI":"10.1074\/jbc.M603670200","article-title":"GPR92 as a new G12\/13- and Gq-coupled lysophosphatidic acid receptor that increases cAMP, LPA5","volume":"281","author":"Lee","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2020.101079_bb0240","doi-asserted-by":"crossref","first-page":"25600","DOI":"10.1074\/jbc.M302648200","article-title":"Identification of p2y9\/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family","volume":"278","author":"Noguchi","year":"2003","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0245","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/ng.84","article-title":"G protein-coupled receptor P2Y5 and its ligand LPA are involved in maintenance of human hair growth","volume":"40","author":"Pasternack","year":"2008","journal-title":"Nat Genet"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0250","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0304-3940(99)00464-4","article-title":"Lysophosphatidic acid-induced, pertussis toxin-sensitive nociception through a substance P release from peripheral nerve endings in mice","volume":"270","author":"Renback","year":"1999","journal-title":"Neurosci Lett"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0255","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0169-328X(99)00333-2","article-title":"Vzg-1\/lysophosphatidic acid-receptor involved in peripheral pain transmission","volume":"75","author":"Renback","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"issue":"7","key":"10.1016\/j.plipres.2020.101079_bb0260","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/nm1060","article-title":"Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling","volume":"10","author":"Inoue","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.plipres.2020.101079_bb0265","doi-asserted-by":"crossref","first-page":"17608","DOI":"10.1074\/jbc.M111.330183","article-title":"Targeted deletion of LPA5 identifies novel roles for lysophosphatidic acid signaling in development of neuropathic pain","volume":"287","author":"Lin","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2020.101079_bb0270","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/1744-8069-5-64","article-title":"Lysophosphatidic acid-3 receptor-mediated feed-forward production of lysophosphatidic acid: An initiator of nerve injury-induced neuropathic pain","volume":"5","author":"Ma","year":"2009","journal-title":"Mol Pain"},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2020.101079_bb0275","doi-asserted-by":"crossref","first-page":"S55","DOI":"10.1097\/j.pain.0000000000000813","article-title":"Lysophosphatidic acid signaling is the definitive mechanism underlying neuropathic pain","volume":"158","author":"Ueda","year":"2017","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0280","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuroscience.2007.12.041","article-title":"Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid","volume":"152","author":"Inoue","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.plipres.2020.101079_bb0285","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1744-8069-4-6","article-title":"Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain","volume":"4","author":"Inoue","year":"2008","journal-title":"Mol Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0290","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/1744-8069-6-78","article-title":"Autotaxin and lysophosphatidic acid1 receptor-mediated demyelination of dorsal root fibers by sciatic nerve injury and intrathecal lysophosphatidylcholine","volume":"6","author":"Nagai","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0295","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1744-8069-6-4","article-title":"The roles of iPLA2, TRPM8 and TRPA1 in chemically induced cold hypersensitivity","volume":"6","author":"Gentry","year":"2010","journal-title":"Mol Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0300","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.pbb.2013.03.002","article-title":"Lysophosphatidylcholine causes neuropathic pain via the increase of neuronal nitric oxide synthase in the dorsal root ganglion and cuneate nucleus","volume":"106","author":"Wang","year":"2013","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.plipres.2020.101079_bb0305","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.neuroscience.2011.03.035","article-title":"Sciatic nerve injury induces functional pro-nociceptive chemokine receptors in bladder-associated primary afferent neurons in the rat","volume":"183","author":"Foster","year":"2011","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0310","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s12974-019-1458-8","article-title":"GPR34 in spinal microglia exacerbates neuropathic pain in mice","volume":"16","author":"Sayo","year":"2019","journal-title":"J Neuroinflammation"},{"issue":"7","key":"10.1016\/j.plipres.2020.101079_bb0315","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1096\/fj.201601183R","article-title":"Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop","volume":"31","author":"Shindou","year":"2017","journal-title":"FASEB J"},{"issue":"6251","key":"10.1016\/j.plipres.2020.101079_bb0320","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1126\/science.aab3516","article-title":"Neuronal Development. Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord","volume":"349","author":"Guy","year":"2015","journal-title":"Science"},{"issue":"6463","key":"10.1016\/j.plipres.2020.101079_bb0325","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar5551","article-title":"Sphingosine 1-phosphate: Lipid signaling in pathology and therapy","volume":"366","author":"Cartier","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0330","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1160\/TH17-04-0291","article-title":"Release of platelet-derived sphingosine-1-phosphate involves multidrug resistance protein 4 (MRP4\/ABCC4) and is inhibited by statins","volume":"118","author":"Vogt","year":"2018","journal-title":"Thromb Haemost"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0335","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"10.1016\/j.plipres.2020.101079_bb0340","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/j.pain.0000000000000965","article-title":"Targeting the S1P\/S1PR1 axis mitigates cancer-induced bone pain and neuroinflammation","volume":"158","author":"Grenald","year":"2017","journal-title":"Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0345","doi-asserted-by":"crossref","first-page":"7833","DOI":"10.1523\/JNEUROSCI.1266-18.2018","article-title":"S1PR3 mediates itch and pain via distinct TRP channel-dependent pathways","volume":"38","author":"Hill","year":"2018","journal-title":"J Neurosci"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0350","doi-asserted-by":"crossref","first-page":"2582","DOI":"10.1523\/JNEUROSCI.4479-12.2013","article-title":"Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor","volume":"33","author":"Camprubi-Robles","year":"2013","journal-title":"J Neurosci"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0355","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1084\/jem.20170584","article-title":"Dysregulation of sphingolipid metabolism contributes to bortezomib-induced neuropathic pain","volume":"215","author":"Stockstill","year":"2018","journal-title":"J Exp Med"},{"issue":"46","key":"10.1016\/j.plipres.2020.101079_bb0360","doi-asserted-by":"crossref","first-page":"15400","DOI":"10.1523\/JNEUROSCI.2391-10.2010","article-title":"Counter-regulation of opioid analgesia by glial-derived bioactive sphingolipids","volume":"30","author":"Muscoli","year":"2010","journal-title":"J Neurosci"},{"issue":"47","key":"10.1016\/j.plipres.2020.101079_bb0365","doi-asserted-by":"crossref","first-page":"32442","DOI":"10.1074\/jbc.M806410200","article-title":"Sphingosine 1-phosphate modulates spinal nociceptive processing","volume":"283","author":"Coste","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.plipres.2020.101079_bb0370","doi-asserted-by":"crossref","first-page":"10557","DOI":"10.1073\/pnas.1820466116","article-title":"Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic pain","volume":"116","author":"Chen","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0375","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1471-4159.2009.05987.x","article-title":"Evidence for lysophosphatidic acid 1 receptor signaling in the early phase of neuropathic pain mechanisms in experiments using Ki-16425, a lysophosphatidic acid 1 receptor antagonist","volume":"109","author":"Ma","year":"2009","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2020.101079_bb0380","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1097\/j.pain.0000000000001316","article-title":"Involvement of lysophosphatidic acid-induced astrocyte activation underlying the maintenance of partial sciatic nerve injury-induced neuropathic pain","volume":"159","author":"Ueda","year":"2018","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0385","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol Pharmacol"},{"issue":"6284","key":"10.1016\/j.plipres.2020.101079_bb0390","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"issue":"5090","key":"10.1016\/j.plipres.2020.101079_bb0395","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0400","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.plipres.2020.101079_bb0405","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","article-title":"Cannabinoids and pain: Sites and mechanisms of action","volume":"80","author":"Starowicz","year":"2017","journal-title":"Adv Pharmacol"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0410","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/nn.3612","article-title":"Peripheral gating of pain signals by endogenous lipid mediators","volume":"17","author":"Piomelli","year":"2014","journal-title":"Nat Neurosci"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0415","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/sj.bjp.0707527","article-title":"The peripheral cannabinoid receptor knockout mice: An update","volume":"153","author":"Buckley","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0420","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1111\/j.1460-9568.2006.04684.x","article-title":"CB2 receptor-mediated antihyperalgesia: possible direct involvement of neural mechanisms","volume":"23","author":"Beltramo","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.plipres.2020.101079_bb0425","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1046\/j.1460-9568.2003.02704.x","article-title":"Induction of CB2 receptor expression in the rat spinal cord of neuropathic but not inflammatory chronic pain models","volume":"17","author":"Zhang","year":"2003","journal-title":"Eur J Neurosci"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0430","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.pain.2008.06.007","article-title":"Cannabinoid receptor CB2 localisation and agonist-mediated inhibition of capsaicin responses in human sensory neurons","volume":"138","author":"Anand","year":"2008","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0435","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0361-9230(03)00045-5","article-title":"The algogenic-induced nociceptive flexion test in mice: Studies on sensitivity of the test and stress on animals","volume":"60","author":"Inoue","year":"2003","journal-title":"Brain Res Bull"},{"issue":"1-2","key":"10.1016\/j.plipres.2020.101079_bb0440","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.pharmthera.2005.06.003","article-title":"Molecular mechanisms of neuropathic pain-phenotypic switch and initiation mechanisms","volume":"109","author":"Ueda","year":"2006","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0445","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1471-4159.2009.06473.x","article-title":"Parathyroid hormone 2 receptor is a functional marker of nociceptive myelinated fibers responsible for neuropathic pain","volume":"112","author":"Matsumoto","year":"2010","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2020.101079_bb0450","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1744-8069-2-16","article-title":"Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test","volume":"2","author":"Matsumoto","year":"2006","journal-title":"Mol Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0455","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1744-8069-4-11","article-title":"Peripheral mechanisms of neuropathic pain - involvement of lysophosphatidic acid receptor-mediated demyelination","volume":"4","author":"Ueda","year":"2008","journal-title":"Mol Pain"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0460","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1124\/jpet.106.103614","article-title":"Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin","volume":"318","author":"Matsumoto","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"issue":"Pt 3","key":"10.1016\/j.plipres.2020.101079_bb0465","first-page":"471","article-title":"The permanent anatomical effects of neonatal capsaicin on somatosensory nerves","volume":"131","author":"Scadding","year":"1980","journal-title":"J Anat"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0470","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1476-5381.2010.00909.x","article-title":"Resolvin D1 attenuates activation of sensory transient receptor potential channels leading to multiple anti-nociception","volume":"161","author":"Bang","year":"2010","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0475","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/s41467-019-13839-2","article-title":"Dorsal root ganglion macrophages contribute to both the initiation and persistence of neuropathic pain","volume":"11","author":"Yu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.plipres.2020.101079_bb0480","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bbi.2020.04.037","article-title":"Macrophages and Schwann cell TRPA1 mediate chronic allodynia in a mouse model of complex regional pain syndrome type I","volume":"88","author":"De Logu","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.plipres.2020.101079_bb0485","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.brainres.2007.12.028","article-title":"Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells","volume":"1196","author":"Li","year":"2008","journal-title":"Brain Res"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0490","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.pain.2005.05.007","article-title":"Activation of NK1 receptor of trigeminal root ganglion via substance P paracrine mechanism contributes to the mechanical allodynia in the temporomandibular joint inflammation in rats","volume":"116","author":"Takeda","year":"2005","journal-title":"Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0495","doi-asserted-by":"crossref","first-page":"9864","DOI":"10.1073\/pnas.0611048104","article-title":"Neuronal somatic ATP release triggers neuron-satellite glial cell communication in dorsal root ganglia","volume":"104","author":"Zhang","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6312","key":"10.1016\/j.plipres.2020.101079_bb0500","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1126\/science.aaf8933","article-title":"Neural circuits for pain: Recent advances and current views","volume":"354","author":"Peirs","year":"2016","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.plipres.2020.101079_bb0505","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1046\/j.1460-9568.2003.02981.x","article-title":"A quantitative and morphological study of projection neurons in lamina I of the rat lumbar spinal cord","volume":"18","author":"Spike","year":"2003","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.plipres.2020.101079_bb0510","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/nrn2947","article-title":"Neuronal circuitry for pain processing in the dorsal horn","volume":"11","author":"Todd","year":"2010","journal-title":"Nat Rev Neurosci"},{"issue":"Pt B","key":"10.1016\/j.plipres.2020.101079_bb0515","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.pnpbp.2017.10.007","article-title":"Pain and consciousness","volume":"87","author":"Garcia-Larrea","year":"2018","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.plipres.2020.101079_bb0520","doi-asserted-by":"crossref","first-page":"108131","DOI":"10.1016\/j.neuropharm.2020.108131","article-title":"Endogenous opioid peptides in the descending pain modulatory circuit","volume":"173","author":"Bagley","year":"2020","journal-title":"Neuropharmacology"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0525","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1097\/j.pain.0000000000001083","article-title":"Brain-derived neurotrophic factor-mediated projection-specific regulation of depressive-like and nociceptive behaviors in the mesolimbic reward circuitry","volume":"159","author":"Liu","year":"2018","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0530","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/nn.3619","article-title":"Why we scratch an itch: The molecules, cells and circuits of itch","volume":"17","author":"Bautista","year":"2014","journal-title":"Nat Neurosci"},{"issue":"9","key":"10.1016\/j.plipres.2020.101079_bb0535","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/1346-8138.13060","article-title":"New therapies for controlling atopic itch","volume":"42","author":"Furue","year":"2015","journal-title":"J Dermatol"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0540","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1038\/nn.3289","article-title":"A subpopulation of nociceptors specifically linked to itch","volume":"16","author":"Han","year":"2013","journal-title":"Nat Neurosci"},{"issue":"7154","key":"10.1016\/j.plipres.2020.101079_bb0545","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/nature06029","article-title":"A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord","volume":"448","author":"Sun","year":"2007","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0550","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.neuron.2010.02.025","article-title":"Loss of inhibitory interneurons in the dorsal spinal cord and elevated itch in Bhlhb5 mutant mice","volume":"65","author":"Ross","year":"2010","journal-title":"Neuron"},{"issue":"6388","key":"10.1016\/j.plipres.2020.101079_bb0555","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1126\/science.aar5703","article-title":"Piezo2 channel-Merkel cell signaling modulates the conversion of touch to itch","volume":"360","author":"Feng","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.plipres.2020.101079_bb0560","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/jnc.14009","article-title":"Serotonergic transmission at Merkel discs: modulation by exogenously applied chemical messengers and involvement of Ih currents","volume":"141","author":"Chang","year":"2017","journal-title":"J Neurochem"},{"issue":"6260","key":"10.1016\/j.plipres.2020.101079_bb0565","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1126\/science.aac8653","article-title":"Gate control of mechanical itch by a subpopulation of spinal cord interneurons","volume":"350","author":"Bourane","year":"2015","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0570","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2340\/0001555565409412","article-title":"Experimental pruritus evoked by platelet activating factor (PAF-acether) in human skin","volume":"65","author":"Fjellner","year":"1985","journal-title":"Acta Derm Venereol"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0575","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S0022-3565(25)24478-0","article-title":"Characterization of a behavioral model for peripherally evoked itch suggests platelet-activating factor as a potent pruritogen","volume":"272","author":"Woodward","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"issue":"1\u20132","key":"10.1016\/j.plipres.2020.101079_bb0580","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.molbrainres.2005.02.029","article-title":"Expression of BLT1 leukotriene B4 receptor on the dorsal root ganglion neurons in mice","volume":"137","author":"Andoh","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0585","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/bjp.2008.220","article-title":"Involvement of the BLT2 receptor in the itch-associated scratching induced by 12-(S)-lipoxygenase products in ICR mice","volume":"154","author":"Kim","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0590","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/sj.jid.5700810","article-title":"Thromboxane A2 induces itch-associated responses through TP receptors in the skin in mice","volume":"127","author":"Andoh","year":"2007","journal-title":"J Invest Dermatol"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0595","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0197-0186(02)00047-5","article-title":"Stimulation of peripheral nociceptor endings by low dose morphine and its signaling mechanism","volume":"41","author":"Ono","year":"2002","journal-title":"Neurochem Int"},{"issue":"151","key":"10.1016\/j.plipres.2020.101079_bb0600","doi-asserted-by":"crossref","DOI":"10.3791\/58943","article-title":"Cheek injection model for simultaneous measurement of pain and itch-related behaviors","author":"Yamanoi","year":"2019","journal-title":"J Vis Exp"},{"key":"10.1016\/j.plipres.2020.101079_bb0605","doi-asserted-by":"crossref","first-page":"24079","DOI":"10.1074\/jbc.M114.572503","article-title":"Structural determinants of the transient receptor potential 1 (TRPV1) channel activation by phospholipid analogs","volume":"289","author":"Morales-Lazaro","year":"2014","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0610","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1038\/nchembio.712","article-title":"Lysophosphatidic acid directly activates TRPV1 through a C-terminal binding site","volume":"8","author":"Nieto-Posadas","year":"2011","journal-title":"Nat Chem Biol"},{"key":"10.1016\/j.plipres.2020.101079_bb0615","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1744-8069-6-85","article-title":"Involvement of lysophosphatidic acid in bone cancer pain by potentiation of TRPV1 via PKCepsilon pathway in dorsal root ganglion neurons","volume":"6","author":"Pan","year":"2010","journal-title":"Mol Pain"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0620","doi-asserted-by":"crossref","first-page":"2681","DOI":"10.1113\/JP273961","article-title":"Lysophosphatidic acid-induced itch is mediated by signalling of LPA5 receptor, phospholipase D and TRPA1\/TRPV1","volume":"595","author":"Kittaka","year":"2017","journal-title":"J Physiol"},{"issue":"2 Pt 1","key":"10.1016\/j.plipres.2020.101079_bb0625","doi-asserted-by":"crossref","first-page":"C450","DOI":"10.1152\/ajpcell.1997.272.2.C450","article-title":"Interleukin-1beta stimulates phospholipase A2 activity in adult rat ventricular myocytes","volume":"272","author":"McHowat","year":"1997","journal-title":"Am J Physiol"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0630","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1016\/j.pain.2011.04.014","article-title":"Patterns of pain: Meta-analysis of microarray studies of pain","volume":"152","author":"LaCroix-Fralish","year":"2011","journal-title":"Pain"},{"issue":"1-2","key":"10.1016\/j.plipres.2020.101079_bb0635","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0169-328X(02)00385-6","article-title":"Sodium channel Na (v)1.6 is expressed along nonmyelinated axons and it contributes to conduction","volume":"105","author":"Black","year":"2002","journal-title":"Brain Res Mol Brain Res"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0640","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuint.2006.09.003","article-title":"LPA-mediated demyelination in ex vivo culture of dorsal root","volume":"50","author":"Fujita","year":"2007","journal-title":"Neurochem Int"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0645","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0896-6273(00)81184-8","article-title":"Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice","volume":"26","author":"Gillespie","year":"2000","journal-title":"Neuron"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0650","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.ejpain.2004.11.005","article-title":"Central pain in multiple sclerosis--prevalence and clinical characteristics","volume":"9","author":"Osterberg","year":"2005","journal-title":"Eur J Pain"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0655","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3959(94)90068-X","article-title":"Pain in the Guillain-Barre syndrome: A clinical review","volume":"59","author":"Pentland","year":"1994","journal-title":"Pain"},{"issue":"6312","key":"10.1016\/j.plipres.2020.101079_bb0660","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1126\/science.aaf8924","article-title":"Pain regulation by non-neuronal cells and inflammation","volume":"354","author":"Ji","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0665","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bja\/87.1.12","article-title":"Mechanisms of neuropathic pain","volume":"87","author":"Bridges","year":"2001","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0670","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1155\/2008\/754260","article-title":"Central poststroke pain: An abstruse outcome","volume":"13","author":"Henry","year":"2008","journal-title":"Pain Res Manag"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0675","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/nrd1107","article-title":"Neurotrophic factors as novel therapeutics for neuropathic pain","volume":"2","author":"Sah","year":"2003","journal-title":"Nat Rev Drug Discov"},{"issue":"9168","key":"10.1016\/j.plipres.2020.101079_bb0680","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1016\/S0140-6736(99)01307-0","article-title":"Neuropathic pain: Aetiology, symptoms, mechanisms, and management","volume":"353","author":"Woolf","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.plipres.2020.101079_bb0685","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1744-8069-4-25","article-title":"Pharmacological switch in Abeta-fiber stimulation-induced spinal transmission in mice with partial sciatic nerve injury","volume":"4","author":"Matsumoto","year":"2008","journal-title":"Mol Pain"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0690","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/glia.23585","article-title":"Lysophosphatidic acid activates satellite glia cells and Schwann cells","volume":"67","author":"Robering","year":"2019","journal-title":"Glia"},{"issue":"3\u20134","key":"10.1016\/j.plipres.2020.101079_bb0695","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.neuint.2008.11.004","article-title":"Profiling of BoNT\/C3-reversible gene expression induced by lysophosphatidic acid: ephrinB1 gene up-regulation underlying neuropathic hyperalgesia and allodynia","volume":"54","author":"Uchida","year":"2009","journal-title":"Neurochem Int"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0700","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1471-4159.2008.05725.x","article-title":"Simultaneous stimulation of spinal NK1 and NMDA receptors produces LPC which undergoes ATX-mediated conversion to LPA, an initiator of neuropathic pain","volume":"107","author":"Inoue","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2020.101079_bb0705","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1744-8069-10-71","article-title":"Lysophosphatidic acid and its receptors LPA1 and LPA3 mediate paclitaxel-induced neuropathic pain in mice","volume":"10","author":"Uchida","year":"2014","journal-title":"Mol Pain"},{"issue":"11","key":"10.1016\/j.plipres.2020.101079_bb0710","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1248\/bpb.b19-00535","article-title":"Systems pathology of neuropathic pain and fibromyalgia","volume":"42","author":"Ueda","year":"2019","journal-title":"Biol Pharm Bull"},{"issue":"1\u20132","key":"10.1016\/j.plipres.2020.101079_bb0715","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pain.2009.07.012","article-title":"Intratrigeminal ganglionic injection of LPA causes neuropathic pain-like behavior and demyelination in rats","volume":"146","author":"Ahn","year":"2009","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.plipres.2020.101079_bb0720","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.joca.2016.08.016","article-title":"Lysophosphatidic acid provides a missing link between osteoarthritis and joint neuropathic pain","volume":"25","author":"McDougall","year":"2017","journal-title":"Osteoarthritis Cartilage"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0725","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jphs.2016.07.010","article-title":"Myelin-related gene silencing mediated by LPA1 - Rho\/ROCK signaling is correlated to acetylation of NFkappaB in S16 Schwann cells","volume":"132","author":"Tsukahara","year":"2016","journal-title":"J Pharmacol Sci"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0730","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bbalip.2012.08.014","article-title":"Lysophosphatidic acid: chemical signature of neuropathic pain","volume":"1831","author":"Ueda","year":"2013","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.plipres.2020.101079_bb0735","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1471-4159.2010.06664.x","article-title":"Calpain-mediated down-regulation of myelin-associated glycoprotein in lysophosphatidic acid-induced neuropathic pain","volume":"113","author":"Xie","year":"2010","journal-title":"J Neurochem"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0740","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2217\/clp.10.88","article-title":"Lysophosphatidic acid as an initiator of neuropathic pain: Biosynthesis and demyelination","volume":"6","author":"Ueda","year":"2011","journal-title":"Clinical Lipidology"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0745","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0304-3940(96)12566-0","article-title":"Sprouting of A beta fibers into lamina II of the rat dorsal horn in peripheral neuropathy","volume":"208","author":"Lekan","year":"1996","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.plipres.2020.101079_bb0750","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1744-8069-4-46","article-title":"Involvement of LPA1 receptor signaling in the reorganization of spinal input through Abeta-fibers in mice with partial sciatic nerve injury","volume":"4","author":"Xie","year":"2008","journal-title":"Mol Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0755","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1744-8069-9-29","article-title":"An LPA species (18:1 LPA) plays key roles in the self-amplification of spinal LPA production in the peripheral neuropathic pain model","volume":"9","author":"Ma","year":"2013","journal-title":"Mol Pain"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0760","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s10571-013-9970-3","article-title":"Interleukin-1beta plays key roles in LPA-induced amplification of LPA production in neuropathic pain model","volume":"33","author":"Yano","year":"2013","journal-title":"Cell Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0765","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1111\/j.1471-4159.2008.05599.x","article-title":"Lysophosphatidic acid-induced membrane ruffling and brain-derived neurotrophic factor gene expression are mediated by ATP release in primary microglia","volume":"107","author":"Fujita","year":"2008","journal-title":"J Neurochem"},{"issue":"Pt 1","key":"10.1016\/j.plipres.2020.101079_bb0770","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1113\/jphysiol.2004.077495","article-title":"Two developmental switches in GABAergic signalling: the K+-Cl- cotransporter KCC2 and carbonic anhydrase CAVII","volume":"562","author":"Rivera","year":"2005","journal-title":"J Physiol"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0775","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/pmt-2019-0036","article-title":"LPA receptor signaling as a therapeutic target for radical treatment of neuropathic pain and fibromyalgia","volume":"10","author":"Ueda","year":"2020","journal-title":"Pain Manag"},{"issue":"7","key":"10.1016\/j.plipres.2020.101079_bb0780","doi-asserted-by":"crossref","first-page":"8833","DOI":"10.1096\/fj.202000317R","article-title":"Conditional Lpar1 gene targeting identifies cell types mediating neuropathic pain","volume":"34","author":"Rivera","year":"2020","journal-title":"FASEB J"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0785","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jphs.2018.01.001","article-title":"LPA5 signaling is involved in multiple sclerosis-mediated neuropathic pain in the cuprizone mouse model","volume":"136","author":"Tsukahara","year":"2018","journal-title":"J Pharmacol Sci"},{"issue":"9","key":"10.1016\/j.plipres.2020.101079_bb0790","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S1474-4422(09)70176-0","article-title":"Central post-stroke pain: clinical characteristics, pathophysiology, and management","volume":"8","author":"Klit","year":"2009","journal-title":"Lancet Neurol"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0795","doi-asserted-by":"crossref","first-page":"e69","DOI":"10.1016\/j.jstrokecerebrovasdis.2015.12.004","article-title":"Catastrophic intracranial hemorrhages after IV tPA in a patient with insidious onset of fever and back pain","volume":"25","author":"Tversky","year":"2016","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.plipres.2020.101079_bb0800","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1212\/01.wnl.0000346325.50431.5f","article-title":"Neuropathic pain: redefinition and a grading system for clinical and research purposes","volume":"72","author":"Ochoa","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/j.plipres.2020.101079_bb0805","doi-asserted-by":"crossref","first-page":"100020","DOI":"10.1016\/j.ynpai.2018.07.001","article-title":"Lysophosphatidic acid LPA1 and LPA3 receptors play roles in the maintenance of late tissue plasminogen activator-induced central poststroke pain in mice","volume":"5","author":"Ueda","year":"2019","journal-title":"Neurobiol Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0810","doi-asserted-by":"crossref","first-page":"e345","DOI":"10.1016\/j.wneu.2018.02.033","article-title":"Traumatic spinal injury: Global epidemiology and worldwide volume","volume":"113","author":"Kumar","year":"2018","journal-title":"World Neurosurg"},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2020.101079_bb0815","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.pain.2012.12.007","article-title":"Pain in patients with spinal cord injury","volume":"154","author":"Finnerup","year":"2013","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0820","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s11916-012-0259-x","article-title":"Spinal cord injury pain: Mechanisms and management","volume":"16","author":"Finnerup","year":"2012","journal-title":"Curr Pain Headache Rep"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0825","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0304-3959(02)00452-9","article-title":"A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury","volume":"103","author":"Siddall","year":"2003","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0830","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1254\/jphs.12080SC","article-title":"Single application of A2 NTX, a botulinum toxin A2 subunit, prevents chronic pain over long periods in both diabetic and spinal cord injury-induced neuropathic pain models","volume":"119","author":"Ma","year":"2012","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0835","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1089\/08977150360547099","article-title":"Experimental modeling of spinal cord injury: Characterization of a force-defined injury device","volume":"20","author":"Scheff","year":"2003","journal-title":"J Neurotrauma"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0840","doi-asserted-by":"crossref","first-page":"9144","DOI":"10.1038\/s41598-019-45742-7","article-title":"Lysophosphatidic acids and their substrate lysophospholipids in cerebrospinal fluid as objective biomarkers for evaluating the severity of lumbar spinal stenosis","volume":"9","author":"Hayakawa","year":"2019","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.plipres.2020.101079_bb0845","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","article-title":"Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis","volume":"35","author":"Russell","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0850","article-title":"Summary of the fibromyalgia research symposium 2016 in Nagasaki","volume":"2","author":"Clauw","year":"2017","journal-title":"Pain Rep"},{"key":"10.1016\/j.plipres.2020.101079_bb0855","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1097\/j.pain.0000000000000285","article-title":"Reduced dermal nerve fiber diameter in skin biopsies of patients with fibromyalgia","volume":"156","author":"Doppler","year":"2015","journal-title":"Pain"},{"issue":"2","key":"10.1016\/j.plipres.2020.101079_bb0860","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.semarthrit.2015.03.003","article-title":"Small fiber neuropathy in women with fibromyalgia. An in vivo assessment using corneal confocal bio-microscopy","volume":"45","author":"Ramirez","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0865","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.1523\/JNEUROSCI.18-08-03043.1998","article-title":"Vagotomy-induced enhancement of mechanical hyperalgesia in the rat is sympathoadrenal-mediated","volume":"18","author":"Khasar","year":"1998","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0870","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/1097-4598(200101)24:1<37::AID-MUS4>3.0.CO;2-8","article-title":"Unilateral intramuscular injections of acidic saline produce a bilateral, long-lasting hyperalgesia","volume":"24","author":"Sluka","year":"2001","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.plipres.2020.101079_bb0875","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1744-8069-4-52","article-title":"Prolonged gabapentin analgesia in an experimental mouse model of fibromyalgia","volume":"4","author":"Nishiyori","year":"2008","journal-title":"Mol Pain"},{"issue":"1-2","key":"10.1016\/j.plipres.2020.101079_bb0880","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.pain.2009.05.024","article-title":"Biogenic amine depletion causes chronic muscular pain and tactile allodynia accompanied by depression: A putative animal model of fibromyalgia","volume":"146","author":"Nagakura","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0885","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ynpai.2017.04.002","article-title":"LPA1 receptor involvement in fibromyalgia-like pain induced by intermittent psychological stress, empathy","volume":"1","author":"Ueda","year":"2017","journal-title":"Neurobiol Pain"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0890","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1124\/jpet.102.033167","article-title":"Chronic muscle pain induced by repeated acid Injection is reversed by spinally administered mu- and delta-, but not kappa-, opioid receptor agonists","volume":"302","author":"Sluka","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.plipres.2020.101079_bb0895","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207310","article-title":"Lysophosphatidic acid is associated with neuropathic pain intensity in humans: An exploratory study","volume":"13","author":"Kuwajima","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0900","doi-asserted-by":"crossref","first-page":"16578","DOI":"10.1038\/s41598-019-52999-5","article-title":"Alteration of the lysophosphatidic acid and its precursor lysophosphatidylcholine levels in spinal cord stenosis: A study using a rat cauda equina compression model","volume":"9","author":"Uranbileg","year":"2019","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0905","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1002\/art.37991","article-title":"Necessity of lysophosphatidic acid receptor 1 for development of arthritis","volume":"65","author":"Miyabe","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.plipres.2020.101079_bb0910","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21041186","article-title":"T cell subpopulations in the physiopathology of fibromyalgia: Evidence and perspectives","volume":"21","author":"Banfi","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.plipres.2020.101079_bb0915","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112296","article-title":"Pharmacological regulation of neuropathic pain driven by inflammatory macrophages","volume":"18","author":"Kiguchi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.plipres.2020.101079_bb0920","doi-asserted-by":"crossref","first-page":"6848","DOI":"10.1523\/JNEUROSCI.3257-18.2019","article-title":"Macrophage toll-like receptor 9 contributes to chemotherapy-induced neuropathic pain in male mice","volume":"39","author":"Luo","year":"2019","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00005-010-0106-x","article-title":"Dual peripheral actions of immune cells in neuropathic pain","volume":"59","author":"Machelska","year":"2011","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0930","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/j.pain.0000000000001122","article-title":"Inflammation in the pathophysiology of neuropathic pain","volume":"159","author":"Sommer","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.plipres.2020.101079_bb0935","article-title":"Role of high-mobility group box 1 and its modulation by thrombomodulin\/thrombin axis in neuropathic and inflammatory pain","author":"Tsujita","year":"2020","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.plipres.2020.101079_bb0940","doi-asserted-by":"crossref","first-page":"6430423","DOI":"10.1155\/2016\/6430423","article-title":"The emerging role of HMGB1 in neuropathic pain: A potential therapeutic target for neuroinflammation","volume":"2016","author":"Wan","year":"2016","journal-title":"J Immunol Res"},{"issue":"4","key":"10.1016\/j.plipres.2020.101079_bb0945","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/jnc.13434","article-title":"Perineural expression of high-mobility group box-1 contributes to long-lasting mechanical hypersensitivity via matrix metalloprotease-9 up-regulation in mice with painful peripheral neuropathy","volume":"136","author":"Zhang","year":"2016","journal-title":"J Neurochem"},{"key":"10.1016\/j.plipres.2020.101079_bb0950","doi-asserted-by":"crossref","first-page":"12029","DOI":"10.1038\/ncomms12029","article-title":"Microglia and monocytes synergistically promote the transition from acute to chronic pain after nerve injury","volume":"7","author":"Peng","year":"2016","journal-title":"Nat Commun"},{"issue":"Suppl. 1","key":"10.1016\/j.plipres.2020.101079_bb0955","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1097\/j.pain.0000000000000389","article-title":"Sex differences in pain: A tale of two immune cells","volume":"157","author":"Mapplebeck","year":"2016","journal-title":"Pain"},{"issue":"1-2","key":"10.1016\/j.plipres.2020.101079_bb0960","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/jnr.23831","article-title":"Sex differences in neuroimmunity and pain","volume":"95","author":"Rosen","year":"2017","journal-title":"J Neurosci Res"},{"issue":"43","key":"10.1016\/j.plipres.2020.101079_bb0965","doi-asserted-by":"crossref","first-page":"15450","DOI":"10.1523\/JNEUROSCI.3859-11.2011","article-title":"Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice","volume":"31","author":"Sorge","year":"2011","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.plipres.2020.101079_bb0970","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3892\/mmr.2016.6018","article-title":"IL-17 contributed to the neuropathic pain following peripheral nerve injury by promoting astrocyte proliferation and secretion of proinflammatory cytokines","volume":"15","author":"Sun","year":"2017","journal-title":"Mol Med Rep"},{"issue":"8","key":"10.1016\/j.plipres.2020.101079_bb0975","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1523\/JNEUROSCI.3681-13.2014","article-title":"Peripheral role of cathepsin S in Th1 cell-dependent transition of nerve injury-induced acute pain to a chronic pain state","volume":"34","author":"Zhang","year":"2014","journal-title":"J Neurosci"},{"issue":"7807","key":"10.1016\/j.plipres.2020.101079_bb0980","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/s41586-020-2235-7","article-title":"Brain control of humoral immune responses amenable to behavioural modulation","volume":"581","author":"Zhang","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.plipres.2020.101079_bb0985","doi-asserted-by":"crossref","first-page":"353","DOI":"10.3389\/fncel.2019.00353","article-title":"Mast cells, neuroinflammation and pain in fibromyalgia syndrome","volume":"13","author":"Theoharides","year":"2019","journal-title":"Front Cell Neurosci"},{"issue":"3","key":"10.1016\/j.plipres.2020.101079_bb0990","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1124\/jpet.115.230060","article-title":"Neuropeptides CRH, SP, HK-1, and inflammatory cytokines IL-6 and TNF are increased in serum of patients with fibromyalgia syndrome, implicating mast cells","volume":"356","author":"Tsilioni","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.plipres.2020.101079_bb0995","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/nm1425","article-title":"Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury","volume":"12","author":"Okada","year":"2006","journal-title":"Nat Med"}],"container-title":["Progress in Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016378272030059X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016378272030059X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:43:24Z","timestamp":1759013004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016378272030059X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":199,"alternative-id":["S016378272030059X"],"URL":"https:\/\/doi.org\/10.1016\/j.plipres.2020.101079","relation":{},"ISSN":["0163-7827"],"issn-type":[{"value":"0163-7827","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathogenic mechanisms of lipid mediator lysophosphatidic acid in chronic pain","name":"articletitle","label":"Article Title"},{"value":"Progress in Lipid Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.plipres.2020.101079","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101079"}}